Correlation Between Neogen and Inhibrx
Can any of the company-specific risk be diversified away by investing in both Neogen and Inhibrx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neogen and Inhibrx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neogen and Inhibrx, you can compare the effects of market volatilities on Neogen and Inhibrx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neogen with a short position of Inhibrx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neogen and Inhibrx.
Diversification Opportunities for Neogen and Inhibrx
Very weak diversification
The 3 months correlation between Neogen and Inhibrx is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding Neogen and Inhibrx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inhibrx and Neogen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neogen are associated (or correlated) with Inhibrx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inhibrx has no effect on the direction of Neogen i.e., Neogen and Inhibrx go up and down completely randomly.
Pair Corralation between Neogen and Inhibrx
Given the investment horizon of 90 days Neogen is expected to under-perform the Inhibrx. But the stock apears to be less risky and, when comparing its historical volatility, Neogen is 1.32 times less risky than Inhibrx. The stock trades about -0.16 of its potential returns per unit of risk. The Inhibrx is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest 1,460 in Inhibrx on December 20, 2024 and sell it today you would lose (60.00) from holding Inhibrx or give up 4.11% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Neogen vs. Inhibrx
Performance |
Timeline |
Neogen |
Inhibrx |
Neogen and Inhibrx Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Neogen and Inhibrx
The main advantage of trading using opposite Neogen and Inhibrx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neogen position performs unexpectedly, Inhibrx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inhibrx will offset losses from the drop in Inhibrx's long position.Neogen vs. Qiagen NV | Neogen vs. Aclaris Therapeutics | Neogen vs. IQVIA Holdings | Neogen vs. Medpace Holdings |
Inhibrx vs. Crinetics Pharmaceuticals | Inhibrx vs. Merus BV | Inhibrx vs. Lyell Immunopharma | Inhibrx vs. Kronos Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Complementary Tools
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |